CHGA and neoplasm: Fragments of chromogranin A (CHGA), an acidic glycoprotein frequently used as a prognostic factor for many neuroendocrine tumours, can affect critical components of the TME, such as fibroblasts and endothelial cells, as well as tumour progression and immunotherapy in patients (11, 12).